405 filings
Page 4 of 21
424B3
q73sxzlf7zfaswla2k02
7 Jan 19
Prospectus supplement
8:17am
424B3
t6xu2w3gax
7 Jan 19
Prospectus supplement
8:14am
6-K
myo685ttz2pz6vk7tzc
7 Jan 19
Intellipharmaceutics Announces Research and Development Program for a Pipeline of Pharmaceutical Cannabidiol Based Products
8:09am
424B3
c7e rlp0wom
6 Dec 18
Prospectus supplement
11:17am
424B3
i5k4y529
6 Dec 18
Prospectus supplement
11:12am
6-K
6t42ytp5
5 Dec 18
Primary Document
12:00am
SC 13G
w3kw lcctpplxclg
30 Nov 18
Intellipharmaceutics International Inc.
5:27pm
424B3
f0yqpa2yqnud
28 Nov 18
Prospectus supplement
2:42pm
424B3
ijig 5gfgl0e3i2kmx6k
28 Nov 18
Prospectus supplement
2:39pm
6-K
umj6pi7vq0ejs
27 Nov 18
Intellipharmaceutics Announces FDA Final Approval of Generic Effexor® XR
5:14pm
424B3
ng3i crps
27 Nov 18
Prospectus supplement
3:36pm
424B3
z9ju5
27 Nov 18
Prospectus supplement
3:22pm
424B3
d140a
27 Nov 18
Prospectus supplement
3:18pm
424B3
nhsq88lhv0jgjnlezk
27 Nov 18
Prospectus supplement
3:15pm
6-K
z32j 8t3acl1bug57tl
27 Nov 18
Primary Document
8:10am
6-K
ly75l091o67hcr8rha
26 Nov 18
Intellipharmaceutics Announces Receipt of Nasdaq Notice
9:37pm
424B3
o6v ztc2w3w
21 Nov 18
Prospectus supplement
5:24pm
424B3
ztl6xwfj 73dib
21 Nov 18
Prospectus supplement
5:22pm
6-K
sel4rh
21 Nov 18
Primary Document
4:30pm
424B3
2vp3vyhxyj8 u4ngcoc
21 Nov 18
Prospectus supplement
11:56am